Molecular classification for endometrial cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study uses a genetic test (looking at the DNA of the tumor) to better understand endometrial cancer. The goal is to improve how doctors classify and potentially treat this cancer, especially for those with advanced stages or certain subtypes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with endometrial cancer (by a tissue sample, called a biopsy).
- You had surgery to remove the cancer, or your cancer is advanced (stage III-IV) and surgery was not possible.
- Your doctor has been following you for at least some time after diagnosis.
- A sample of your tumor from the hospital can be used for this study (it must be big enough and well-preserved).
- You have not had chemotherapy or radiation before your surgery (called neo-adjuvant treatment).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at combining genetic testing with surgical exams to better understand endometrial cancer. It may help doctors see which treatments could work best for you.
This study looks at women with certain high-risk types of endometrial cancer that have not spread into the muscle wall of the uterus. It aims to understand how these cancers behave and whether lymph node testing is needed, which could help guide treatment decisions.
This trial studies tumor DNA in blood and tissue from people with aggressive endometrial cancer to better understand the disease. You donate samples during surgery and follow-up visits.
This study looks at how genetic features of early-stage endometrial cancer affect the success of fertility-sparing treatments. It aims to help women under 45 who want to preserve their fertility understand their treatment options.
This study looks at the specific type of endometrial cancer (endometrioid) in Mexican patients to understand how different molecular features affect prognosis. It may help doctors better tailor treatment to the individual.
This study looks for “methylated DNA markers” (special DNA patterns) to help detect endometrial, ovarian, and cervical cancers, and to support doctors around planned procedures. It may help find cancer earlier or better sort out who needs closer treatment.
Hear when a new Endometrial Cancer, Endometrial Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.